Phase 2 Congestive Heart Failure Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
Congestive Heart Failure
Iperboreal Pharma Srl84 enrolled3 locationsNCT03994874
Recruiting
Phase 1Phase 2
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Heart FailureCongestive Heart FailureHFrEF - Heart Failure With Reduced Ejection Fraction+1 more
Sardocor Corp.57 enrolled5 locationsNCT04703842
Not Yet Recruiting
Phase 2
Breathe Easy Early Study (BEES): A randomised control study assessing the efficacy of early intervention with humidified high flow nasal cannula in the emergency department-Optimising outcomes in the Golden Hour of Respiratory failure.
Respiratory illnessesAcute Respiratory illnessesCongestive Heart Failure
Ipswich Hospital268 enrolled1 locationACTRN12616000587404
Terminated
Phase 2
A Phase 2 Multi-Centre Study to Characterise the Pharmacodynamics of Vessel Dilator Peptide (VSDL) in Patients with Acute Decompensated Congestive Heart Failure to be assessed by effects on renal function.
Acute Decompensated Congestive Heart Failure
South Australian Health and Medical Research Institute65 enrolled1 locationACTRN12613001060730
Withdrawn
Phase 2
Pilot trial of Aspirin versus Ticagrelor in Congestive Heart Failure
Congestive Heart failure patientsHeart Failure
St Vincent's Hospital, Heart Failure Research Trust Fund #86988330 enrolled1 locationACTRN12613000826741
Not Yet Recruiting
Phase 2
To evaluate the effects on time to clinical stability associated with treatment with peramivir administered intravenously compared to oral oseltamivir in adults hospitalized with acute serious or potentially life-threatening influenza
Life threatening comorbidities suchs as COPD, congestive heart failure and diabetes.Influenza
BioCryst Pharmaceuticals Inc.120 enrolledACTRN12607000282482